Amphastar Pharmaceuticals (AMPH) Non-Current Deffered Revenue (2013 - 2017)
Amphastar Pharmaceuticals (AMPH) posted quarterly Non-Current Deffered Revenue of $1.2 million for Q3 2017, up 623.21% year-over-year from $168000.0 in Q3 2016, and up 187.23% quarter-over-quarter from $423000.0 in Q2 2017.
Amphastar Pharmaceuticals (AMPH) Non-Current Deffered Revenue (2013 - 2017) Analysis & Trends
Amphastar Pharmaceuticals' Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $1.2 million for Q3 2017.
- In Q3 2017, Non-Current Deffered Revenue rose 623.21% year-over-year to $1.2 million; the TTM figure through Sep 2017 stood at $1.2 million (up 623.21% YoY), while the FY2016 annual figure was $97000.0, down 92.76% from the prior year.
- Non-Current Deffered Revenue for Q3 2017 stood at $1.2 million, up from $423000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $2.6 million in Q4 2013, with the low at $97000.0 in Q4 2016.
- The 5-year median for Non-Current Deffered Revenue is $1.3 million (2015), against an average of $1.3 million.
- The sharpest annual moves came in 2016 and 2017: Non-Current Deffered Revenue slumped 92.76% in 2016, then surged 623.21% in 2017.
- Amphastar Pharmaceuticals' Non-Current Deffered Revenue stood at $2.6 million in 2013, then declined by 24.5% to $2.0 million in 2014, then plunged by 32.44% to $1.3 million in 2015, then plunged by 92.76% to $97000.0 in 2016, then soared by 1152.58% to $1.2 million in 2017.
- Business Quant data shows AMPH's Non-Current Deffered Revenue at $1.2 million in Q3 2017, $423000.0 in Q2 2017, and $280000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 1.22 Mn |
| Jun 30, 2017 | 423,000.00 |
| Mar 31, 2017 | 280,000.00 |
| Dec 31, 2016 | 97,000.00 |
| Sep 30, 2016 | 168,000.00 |
| Jun 30, 2016 | 166,000.00 |
| Mar 31, 2016 | 1.18 Mn |
| Dec 31, 2015 | 1.34 Mn |
| Sep 30, 2015 | 1.50 Mn |
| Jun 30, 2015 | 1.66 Mn |
| Mar 31, 2015 | 1.82 Mn |
| Dec 31, 2014 | 1.98 Mn |
| Sep 30, 2014 | 2.14 Mn |
| Jun 30, 2014 | 2.30 Mn |
| Dec 31, 2013 | 2.63 Mn |